CLINICAL_TRIALS
trial_result
· 2022-07-07
Clinical Trial Update: A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis [Phase 4]
Summary
A Phase 4 clinical trial update evaluating safety and efficacy of ruxolitinib in myelofibrosis using a prognostic-stratification approach.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Qilu Hospital of Shandong University | Conditions: Myelofibrosis | Phase 4 | Status: UNKNOWN